FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates

FibroGen (FGEN) came out with a quarterly loss of $1.61 per share versus the Zacks Consensus Estimate of a loss of $4.01. This compares to a loss of $4.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +59.85%. A quarter ago, it was expected that this biotech drug developer would post a loss of $2.25 per share when it actually produced a loss of $3.38, delivering a surprise of -50.22%.Over the last four quarters, the company ...